Cargando…
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality despite efforts to improve standard interventions. As CRC patients can benefit from immunotherapeutic strategies that incite effector T cell action, cancer vaccines represent a safe and promising therapeutic approach to elic...
Autores principales: | Anderson, Trevor S., McCormick, Amanda L., Daugherity, Elizabeth A., Oladejo, Mariam, Okpalanwaka, Izuchukwu F., Smith, Savanna L., Appiah, Duke, Wood, Laurence M., Lowe, Devin B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540654/ https://www.ncbi.nlm.nih.gov/pubmed/37781234 http://dx.doi.org/10.1080/2162402X.2023.2260620 |
Ejemplares similares
-
Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression
por: McCormick, Amanda L., et al.
Publicado: (2023) -
Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies
por: Oladejo, Mariam, et al.
Publicado: (2021) -
RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension
por: Lu, Guofang, et al.
Publicado: (2023) -
Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma
por: Oladejo, Mariam, et al.
Publicado: (2022) -
RGS5: a novel role as a hypoxia-responsive protein that suppresses chemokinetic and chemotactic migration in brain pericytes
por: Enström, Andreas, et al.
Publicado: (2022)